GlassScriptPhysician profile
Amber Wilson
NPI 1437673266
$11,743.32
in general payments reported to CMS, 2019-2025
69 companies · $2,025 in 2025
The $2,025 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,188 · 2022: $2,564 · 2023: $3,952 · 2024: $2,015 · 2025: $2,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,387 · Education: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,387.05 |
| Education | $605.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $841.50 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Seagen INC. | $839.64 | 2021-2023 | Padcev, Tukysa, Adcetris |
| Novartis Pharmaceuticals Corporation | $663.79 | 2021-2025 | |
| Abbvie INC. | $557.94 | 2022-2025 | |
| Janssen Biotech, INC. | $519.12 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| Astrazeneca Pharmaceuticals LP | $460.28 | 2021-2025 | Lynparza, Calquence, Imfinzi |
| Daiichi Sankyo INC. | $419.68 | 2021-2025 | Injectafer, Enhertu, Vanflyta |
| Astellas Pharma US INC | $418.77 | 2021-2025 | Xtandi, Padcev |
| Pfizer INC. | $418.28 | 2022-2025 | |
| Amgen INC. | $417.29 | 2021-2023 | Kyprolis, Blincyto, Lumakras |
| Aveo Pharmaceuticals, INC. | $408.53 | 2022-2025 | Fotivda |
| Regeneron Healthcare Solutions, INC. | $316.77 | 2021-2025 | Libtayo |
| Genzyme Corporation | $307.37 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $305.78 | 2021-2025 | Ninlaro, Iclusig |
| Genentech USA, INC. | $224.67 | 2021-2025 | Polivy, Lunsumio, Venclexta |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $213.81 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Bayer Healthcare Pharmaceuticals INC. | $211.51 | 2022-2025 | |
| Stemline Therapeutics INC. | $211.49 | 2023-2025 | Orserdu |
| Gilead Sciences, INC. | $207.10 | 2022-2025 | Trodelvy |
| Incyte Corporation | $205.06 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Alexion Pharmaceuticals, INC. | $195.63 | 2021-2025 | Ultomiris |
| Exelixis INC. | $181.87 | 2022-2024 | Cabometyx |
| Karyopharm Therapeutics INC. | $181.57 | 2022-2024 | Xpovio |
| Celgene Corporation | $178.00 | 2021-2025 | Reblozyl, Opdualag, Pomalyst |
| Beigene USA, INC. | $165.69 | 2021-2024 | Brukinsa |
| Jazz Pharmaceuticals INC. | $163.29 | 2021-2024 | |
| Eisai INC. | $160.27 | 2021-2025 | |
| Lilly USA, LLC | $151.26 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Servier Pharmaceuticals LLC | $125.96 | 2022-2025 | |
| Blueprint Medicines Corporation | $124.73 | 2021-2025 | Ayvakit |
| Myriad Genetic Laboratories, INC. | $117.38 | 2022-2024 | Precisetumor, Myrisk |
| Sun Pharmaceutical Industries INC. | $104.14 | 2022-2024 | Yonsa |
| Coherus Oncology, INC. | $103.06 | 2023-2025 | Udenyca, Loqtorzi |
| Pharmacyclics LLC, An Abbvie Company | $102.61 | 2021-2023 | Imbruvica |
| Puma Biotechnology, INC. | $99.87 | 2023-2024 | Nerlynx |
| Sanofi-Aventis U.S. LLC | $98.00 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $96.48 | 2021-2023 | Opdivo |
| Adaptive Biotechnologies Corporation | $94.75 | 2023-2024 | Clonoseq |
| Ipsen Biopharmaceuticals, INC | $71.07 | 2021-2024 | Onivyde, Tazverik |
| Rigel Pharmaceuticals, INC. | $62.27 | 2025 | Tavalisse, Rezlidhia, Gavreto |
| Geron Corporation | $61.48 | 2025 | Rytelo |
| Deciphera Pharmaceuticals INC. | $58.00 | 2021-2023 | Qinlock |
| Sobi, INC | $56.68 | 2023-2025 | |
| Mirati Therapeutics, INC. | $55.10 | 2023 | Krazati |
| Agios Pharmaceuticals, INC. | $54.22 | 2024-2025 | Pyrukynd |
| Tersera Therapeutics LLC | $53.01 | 2023-2025 | Xermelo, Quzyttir |
| Epizyme, INC. | $52.37 | 2021-2022 | |
| Adc Therapeutics America, INC. | $48.67 | 2022 | |
| G1 Therapeutics, INC. | $41.84 | 2023 | Cosela |
| Organon LLC | $41.35 | 2023-2025 | Ontruzant |
| Emmaus Medical, INC. | $40.12 | 2021-2023 | Endari |
| Fresenius Kabi USA, LLC | $38.39 | 2025 | Stimufend |
| Pharmacosmos Therapeutics INC. | $35.00 | 2024 | Cosela, Monoferric |
| Taiho Oncology, INC. | $34.80 | 2025 | |
| Morphosys, US INC. | $34.16 | 2021-2022 | |
| Iovance Biotherapeutics, INC. | $32.49 | 2025 | Amtagvi |
| Springworks Therapeutics, INC. | $28.67 | 2025 | Gomekli |
| Kite Pharma, INC. | $24.34 | 2025 | Yescarta |
| Syndax Pharmaceuticals, INC. | $23.18 | 2025 | |
| Beone Medicines USA, INC. | $22.40 | 2025 | Brukinsa |
| Janssen Pharmaceuticals, INC | $20.46 | 2025 | Erleada |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.20 | 2023 | Gilotrif |
| Legend Biotech USA INC. | $18.93 | 2025 | Carvykti |
| Octapharma USA, INC. | $18.82 | 2025 | Octagam Immune Globulin (Human) |
| Acrotech Biopharma INC. | $18.72 | 2025 | Beleodaq |
| Foundation Medicine, INC. | $18.62 | 2022 | |
| Array Biopharma INC | $17.20 | 2025 | Braftovi, Mektovi, Tukysa |
| Fennec Pharmaceuticals, INC. | $16.36 | 2025 | Fyarro |
| Acceleron Pharma, INC. | $11.46 | 2021 |
Drugs and devices associated with these payments
Keytruda $514Venclexta $395Xtandi $272Kisqali $266Libtayo $245Fotivda $239Ninlaro $231Padcev $229Lynparza $219Orserdu $211Tukysa $198Darzalex $179Tecvayli $163Piqray $140Imbruvica $133Injectafer $129Sarclisa $128Ibrance $123Enhertu $121Ultomiris $120Talvey $120Elitek $115Xpovio $115Ayvakit $108Epkinly $104Gavreto $102Verzenio $102Jaypirca $102Brukinsa $102Calquence $102Elrexfio $97.44Clonoseq $94.75Trodelvy $94.16Ojjaara $88.82Zepzelca $88.61Polivy $88.06Udenyca $87.22Adcetris $82.89Lenvima $77.70Lunsumio $69.32Kyprolis $65.11Reblozyl $64.53Nubeqa $63.09Rezlidhia $62.27Tavalisse $62.27Rytelo $61.48Cabometyx $60.31Cosela $60.28Precisetumor $57.02Welireg $56.59Besponsa $56.50Bosulif $56.50Jakafi $55.70Krazati $55.10Iclusig $53.14Stivarga $52.98Inlyta $50.93Tibsovo $50.08Blincyto $48.82Erleada $47.94Opdivo $47.02Myrisk $46.80Lumakras $45.09Yonsa $44.50Braftovi $43.28Ontruzant $41.35Retevmo $41.18Rozlytrek $40.03Tecentriq $40.03Avastin $40.03Opdualag $39.64Pluvicto $39.55Stimufend $38.39Vitrakvi $38.38Vectibix $38.12Xgeva $38.12Nplate $38.12Onivyde $37.50Pyrukynd $37.45Monjuvi $37.40Imfinzi $36.66Talzenna $35.27Orgovyx $35.27Lonsurf $34.80Inqovi $34.80Scemblix $34.43Wayrilz $33.92Amtagvi $32.49Bavencio $32.20Jemperli $31.39Zejula $31.39Shingrix $30.95Xermelo $30.26Mektovi $29.44Gomekli $28.67Endari $28.29Fabhalta $27.35Qinlock $26.49Xofigo $25.58Rybrevant $24.95
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.